home / stock / armp / armp short
Short Information | Armata Pharmaceuticals Inc. (NYSE:ARMP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,974 |
Total Actual Volume | 323,246 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 149 |
Average Short Percentage | 0.69% |
Is there a ARMP Short Squeeze or Breakout about to happen?
See the ARMP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-05-2024 | $2.79 | $2.625 | $2.79 | $2.61 | 7,148 | 74 | 1.04% |
05-24-2024 | $2.59 | $2.62 | $2.67 | $2.58 | 5,309 | 25 | 0.47% |
05-23-2024 | $2.635 | $2.6 | $2.69 | $2.6 | 5,702 | 1 | 0.02% |
05-21-2024 | $2.6154 | $2.57 | $2.76 | $2.45 | 18,328 | 79 | 0.43% |
05-20-2024 | $2.56 | $2.48 | $2.88 | $2.3 | 27,471 | 101 | 0.37% |
05-17-2024 | $2.74 | $2.59 | $3.13 | $2.55 | 23,131 | 201 | 0.87% |
05-16-2024 | $2.94 | $2.65 | $3 | $2.52 | 23,463 | 28 | 0.12% |
05-14-2024 | $3.21 | $2.92 | $3.21 | $2.89 | 17,232 | 132 | 0.77% |
05-10-2024 | $3.38 | $3.0912 | $3.4 | $2.915 | 9,786 | 100 | 1.02% |
05-09-2024 | $2.91 | $3.26 | $3.45 | $2.8627 | 23,703 | 84 | 0.35% |
05-08-2024 | $2.82 | $2.76 | $2.83 | $2.76 | 6,076 | 35 | 0.58% |
05-07-2024 | $2.74 | $2.86 | $3.33 | $2.55 | 45,482 | 731 | 1.61% |
05-02-2024 | $2.51 | $2.49 | $2.5867 | $2.46 | 6,863 | 13 | 0.19% |
05-01-2024 | $2.5028 | $2.4 | $2.64 | $2.4 | 9,028 | 1 | 0.01% |
04-25-2024 | $2.53 | $2.5308 | $2.59 | $2.53 | 4,683 | 1 | 0.02% |
04-22-2024 | $2.705 | $2.51 | $2.85 | $2.51 | 5,098 | 82 | 1.61% |
04-18-2024 | $2.6 | $2.55 | $2.8 | $2.5 | 31,040 | 1,258 | 4.05% |
04-17-2024 | $3.3 | $2.5 | $3.3 | $2.5 | 34,486 | 2 | 0.01% |
04-11-2024 | $3.43 | $3.31 | $3.46 | $3.31 | 6,525 | 3 | 0.05% |
04-10-2024 | $3.54 | $3.4 | $3.85 | $3.4 | 12,692 | 23 | 0.18% |
News, Short Squeeze, Breakout and More Instantly...
Armata Pharmaceuticals Inc. Company Name:
ARMP Stock Symbol:
NYSE Market:
Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update PR Newswire LOS ANGELES , May 7, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on high...
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update PR Newswire LOS ANGELES , March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology com...
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva PR Newswire Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES , March 4, 20...